JPWO2023104185A5 - - Google Patents
Info
- Publication number
- JPWO2023104185A5 JPWO2023104185A5 JP2024534426A JP2024534426A JPWO2023104185A5 JP WO2023104185 A5 JPWO2023104185 A5 JP WO2023104185A5 JP 2024534426 A JP2024534426 A JP 2024534426A JP 2024534426 A JP2024534426 A JP 2024534426A JP WO2023104185 A5 JPWO2023104185 A5 JP WO2023104185A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- cas12b
- engineered
- acid residues
- nuclease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021136761 | 2021-12-09 | ||
| CNPCT/CN2021/136761 | 2021-12-09 | ||
| PCT/CN2022/137920 WO2023104185A1 (en) | 2021-12-09 | 2022-12-09 | Engineered cas12b effector proteins and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025501473A JP2025501473A (ja) | 2025-01-22 |
| JP2025501473A5 JP2025501473A5 (https=) | 2025-12-17 |
| JPWO2023104185A5 true JPWO2023104185A5 (https=) | 2025-12-17 |
Family
ID=86686936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534426A Pending JP2025501473A (ja) | 2021-12-09 | 2022-12-09 | エンジニアリングされたＣａｓ１２ｂエフェクタータンパク質及びその使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250051742A1 (https=) |
| EP (1) | EP4444875A4 (https=) |
| JP (1) | JP2025501473A (https=) |
| CN (2) | CN118339285A (https=) |
| WO (1) | WO2023104185A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025067403A1 (zh) * | 2023-09-28 | 2025-04-03 | 上海天泽云泰生物医药有限公司 | 用于治疗血红蛋白疾病的组合物和方法 |
| TW202521691A (zh) * | 2023-10-06 | 2025-06-01 | 美商藍岩醫療公司 | 經工程化之v型rna可程式核酸內切酶及其用途 |
| WO2025096367A1 (en) * | 2023-11-03 | 2025-05-08 | University Of Florida Research Foundation, Inc. | Thermostable and/or charge-engineered cas12a variants for nucleic acid detection |
| CN120330162A (zh) * | 2023-12-06 | 2025-07-18 | 尧唐(上海)生物科技有限公司 | 一种Cas蛋白、包含其的CRISPR-Cas系统及其应用 |
| WO2026060637A1 (en) * | 2024-09-20 | 2026-03-26 | Shanghai Vitalgen Biopharma Co., Ltd. | Engineered mrna for gene editing using crispr/cas12b |
| CN120796267A (zh) * | 2024-07-05 | 2025-10-17 | 上海天泽云泰生物医药有限公司 | 用于使用CRISPR/Cas系统进行基因编辑的经修饰的gRNA |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019127087A1 (zh) * | 2017-12-27 | 2019-07-04 | 中国科学院动物研究所 | 基因组编辑系统和方法 |
| PL3765615T3 (pl) * | 2018-03-14 | 2023-11-13 | Arbor Biotechnologies, Inc. | Nowe enzymy i układy crispr ukierunkowane na dna |
| US20210292747A1 (en) * | 2018-07-27 | 2021-09-23 | The Regents Of The University Of Colorado, A Body Corporate | Engineered chimeric nucleic acid guided nucleases compositions, methods for making, and systems for gene editing |
| CN113286884A (zh) * | 2018-08-07 | 2021-08-20 | 博德研究所 | 新型cas12b酶和系统 |
| EP3861112A4 (en) * | 2018-10-04 | 2022-09-21 | The Regents of the University of Colorado, A Body Corporate | ENGINEERED CHIMERIC NUCLEIC ACID-GUIDED NUCLEAR CONSTRUCTS AND THEIR USES |
| BR112022007125A2 (pt) * | 2019-10-17 | 2022-07-05 | Pairwise Plants Services Inc | Variantes de nucleases cas12a e métodos de produção e uso das mesmas |
| WO2021178934A1 (en) * | 2020-03-06 | 2021-09-10 | Metagenomi Ip Technologies, Llc | Class ii, type v crispr systems |
| CN113308451B (zh) * | 2020-12-07 | 2023-07-25 | 中国科学院动物研究所 | 工程化的Cas效应蛋白及其使用方法 |
| CN115851665B (zh) * | 2021-05-27 | 2025-01-24 | 中国科学院动物研究所 | 工程化的Cas12i核酸酶及其效应蛋白以及用途 |
| WO2022247873A1 (zh) * | 2021-05-27 | 2022-12-01 | 中国科学院动物研究所 | 工程化的Cas12i核酸酶、效应蛋白及其用途 |
-
2022
- 2022-12-09 CN CN202280079229.1A patent/CN118339285A/zh active Pending
- 2022-12-09 WO PCT/CN2022/137920 patent/WO2023104185A1/en not_active Ceased
- 2022-12-09 CN CN202211581644.5A patent/CN116254246B/zh active Active
- 2022-12-09 US US18/717,976 patent/US20250051742A1/en active Pending
- 2022-12-09 EP EP22903602.5A patent/EP4444875A4/en active Pending
- 2022-12-09 JP JP2024534426A patent/JP2025501473A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7761294B2 (ja) | 遺伝子編集における非意図的な変異の阻害 | |
| AU2021201257B2 (en) | Cas9 variants and uses thereof | |
| JP7149599B2 (ja) | 操作された転写活性化因子様エフェクター（ｔａｌｅ）ドメインおよびその使用 | |
| JP7679311B2 (ja) | プログラム可能塩基エディターシステムを用いた一塩基多型編集法 | |
| JP2025013768A (ja) | プログラム可能塩基エディターシステムを用いて病原性変異を抑制する方法 | |
| AU2025202331A9 (en) | Delivery and use of the CRISPR-Cas systems, vectors and compositions for hepatic targeting and therapy | |
| JP2024138268A (ja) | プログラム可能な塩基エディターシステムを用いて単一ヌクレオチド多型を編集する方法 | |
| KR20200121782A (ko) | 아데노신 염기 편집제의 용도 | |
| US20190382775A1 (en) | Truncated crispr-cas proteins for dna targeting | |
| KR20220150329A (ko) | 클래스 ii, 타입 v crispr 시스템 | |
| CA3009194A1 (en) | Chimeric proteins and methods of regulating gene expression | |
| US20260043013A1 (en) | Single base substitution protein, and composition comprising same | |
| US20220389418A1 (en) | Rna-guided cas nucleases and uses thereof in diagnostics and therapy | |
| JPWO2023104185A5 (https=) | ||
| JP2021522825A (ja) | ＣＲＩＳＰＲ／Ｃａｓ９システムおよびその使用 | |
| Rousseau et al. | Transposition of IS 911 | |
| JP2024501892A (ja) | 新規の核酸誘導型ヌクレアーゼ | |
| CN116438302A (zh) | 用于对货物核苷酸序列转位的系统和方法 | |
| CN116790566B (zh) | 一种具有新的碱基编辑功能的核酸酶及编辑系统 | |
| WO2024173573A1 (en) | Crispr-transposon systems and components | |
| EP4165182A2 (en) | Genetic modification | |
| WO2024235991A1 (en) | Rna-guided nucleases and nucleic acid targeting systems comprising such rna-guided nucleases | |
| Whitfield et al. | Formation, characterization and partial purification of a Tn5 strand transfer complex | |
| JPWO2023191073A5 (https=) | ||
| CN115820603A (zh) | 一种基于dCasRx-NSUN6单基因特异性M5C修饰编辑方法 |